In conclusion, PD-1 monoclonal antibodies in tumor-associated macrophages can inhibit the migration and angiogenesis of cervical cancer cells by affecting the PD-1/IRE1α/SHP2/HIF1α signaling pathway, thereby inhibiting the progression of cervical cancer (Figure 6). The gene discussed is ERN1; the disease is cervical carcinoma.